Found 9 articles for: "diabetes mellitus"
Association Between Sodium-Glucose Cotransporter-2 Inhibitors and Vulvar Pruritus Without Vulvovaginal Candidiasis: A TriNetX-Based Analysis
October 2026 | Volume 25 | Issue 10 | Editorials | e89 | Copyright © October 2026
GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity
August 2026 | Volume 25 | Issue 8 | Features | 753 | Copyright © August 2026
Myo-Inositol in Pregnancy: Implications for Acne Management
July 2026 | Volume 25 | Issue 7 | Original Article | 611 | Copyright © July 2026
Background: Acne vulgaris is common during pregnancy and presents unique therapeutic challenges due to fetal safety considerations and restrictions on conventional acne medicatio...
Read MoreThe Emerging Role of Metformin in Skin Cancer: Mechanistic and Clinical Insights
May 2026 | Volume 25 | Issue 5 | Original Article | 444 | Copyright © May 2026
Background: Metformin, widely used for type 2 diabetes mellitus, has demonstrated antitumor effects through modulation of metabolic and immune pathways. This review explores its ...
Read MoreThe Safety of GLP1 Receptor Agonist Usage in Mohs Micrographic Surgery Patients
April 2026 | Volume 25 | Issue 4 | Editorials | 394 | Copyright © April 2026
Glucagon-Like Peptide-1 Receptor Agonists Reduce Surgeries and Hospitalizations in Hidradenitis Suppurativa: A Multicenter TriNetX Cohort Study
September 2025 | Volume 24 | Issue 9 | Original Article | 869 | Copyright © September 2025
Background: Hidradenitis suppurativa is a chronic inflammatory skin condition frequently associated with type 2 diabetes mellitus and obesity. Glucagon-like peptide-1 receptor ag...
Read MoreA Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies
April 2025 | Volume 24 | Issue 4 | Features | 413 | Copyright © April 2025
Glucagon-like peptide-1 (GLP-1) agonists are used to treat type 2 diabetes mellitus (T2DM) and have recently gained approval and popularity for treating obesity and weight loss. There is a lack o...
Read MoreAlgorithm to Improve Patient Comfort and Treat Diabetes Mellitus-Related Xerosis
April 2023 | Volume 22 | Issue 4 | Original Article | 356 | Copyright © April 2023
Background: Diabetes mellitus (DM)-related cutaneous disorders such as xerosis frequently occur in patients with type 1 and type 2 diabetes. Gentle cleansers and moisturizers are...
Read MoreAn International Evaluation of a Ceramide-Containing Hydrating Cleanser and Moisturizing Cream for the Improvement of Diabetes Mellitus-Related Xerosis
January 2023 | Volume 22 | Issue 1 | Original Article | 65 | Copyright © January 2023
Background: Diabetes mellitus (DM) is a common disease. Seventy percent of patients present with a cutaneous complication, including xerosis. Ceramides-containing (CER) skincare promo...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
